Posts Tagged ‘Biosimilars’

  • Biosimilars for Rheumatoid Arthritis: 5 Facts

    Discussion of the distinction between biosimilars and biologic originators and the cost and approval process of biosimilars for rheumatoid arthritis.

  • News on Biosimilar Biologics for Rheumatoid Arthritis / Rheumatoid Disease

    Little progress on FDA path of biosimilar biologics for RD It’s hard to believe it’s been almost two years since we’ve discussed biosimilars on Rheumatoid Arthritis Warrior (RAW). What’s even harder to believe: the situation in the U.S. is much the same: 1) The Biologics Price Competition and Innovation Act (BPCI) was created as a […]

  • Are Biosimilars Justice in Competition for Biologics Like Enbrel?

    The FDA definition of biosimilars and a pathway to approval Biosimilars are pharmaceuticals that are similar to biologics such as Enbrel and Humira, but not chemically identical as with generic drugs. If the unique molecules used to create a biologic (from living proteins) such as Enbrel are not cloned, but carefully imitated, they are considered […]

Would You Like Free Email Updates?
Stay in touch with RA Warrior.
We respect your privacy. Your email address will never be shared.